This report contains over 1,000 links to online copies of actual
companion diagnostics deals. In addition contract documents as submitted to the
Securities Exchange Commission by companies and their partners are available
where they have been disclosed. Contract documents provide the answers to
numerous questions about a prospective partner’s flexibility on a wide range of
important issues, many of which will have a significant impact on each party’s
ability to derive value from the deal.
The initial chapters of this report provide an orientation of companion
diagnostics dealmaking and business activities. Chapter 1 provides an
introduction to the report, whilst chapter 2 provides an overview of the trends
in companion diagnostics dealmaking since 2007.
Request a Sample for or Inquire before
buying the report@
Companion
Diagnostics Partnering Terms and Agreements
Companion Diagnostics
Partnering Terms and Agreements includes:
·
Trends in companion
diagnostics dealmaking in the biopharma industry since 2007
·
Analysis of
companion diagnostics deal structure
·
Links to online
access to over 1,000 companion diagnostics deals
·
The leading
companion diagnostics deals by value since 2007
·
Most active
companion diagnostics dealmakers since 2007
·
The leading
companion diagnostics partnering resources
In Companion
Diagnostics Partnering Terms and Agreements, the available contracts are listed
by:
·
Company A-Z
·
Headline value
·
Stage of
development at signing
·
Deal component
type
·
Specific therapy
target
Major points
covered in Table of Contents of this report include:
Executive Summary
Introduction
Trends in companion diagnostic
dealmaking
Leading companion diagnostic deals
Bigpharma companion diagnostic deals
Companion diagnostic dealmaking
directory
Companion diagnostics partnering
resource center
See More Pharmaceuticals Market Research Reports
Report Details :
Published: February 2012
Published: February 2012
No. of Pages:
Price: Single User License – US $ 2695
No comments:
Post a Comment